The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients
1 other identifier
observational
N/A
1 country
1
Brief Summary
In this study, we evaluate the acute coronary syndrome patients to see if there is correlation between platelet activity, genetic polymorphism (CYP2C19 and ABCB1), serum adipokines level, and Clopidogrel responsiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2010
CompletedFirst Posted
Study publicly available on registry
December 7, 2010
CompletedDecember 7, 2010
December 1, 2010
December 6, 2010
December 6, 2010
Conditions
Keywords
Study Arms (3)
Acute coronary syndrome patients
Chronic coronary artery disease patients
Healthy control
Eligibility Criteria
Acute coronary syndrome and chronic coronary artery diseae patients
You may qualify if:
- Age \> 18 y/o
- Acute coronary syndrome patients
- Chronic coronary artery disease patients
- Healthy volunteers
You may not qualify if:
- Patient refusal
- Allergy to Clopidogrel
- Receive Gp IIb/IIIa inhibitor simultaneously
- Cancer history
- Severe renal and liver function impairment
- Coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University Hospital
Taichung, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 6, 2010
First Posted
December 7, 2010
Last Updated
December 7, 2010
Record last verified: 2010-12